Lung function: FEV1 mL (change from baseline) · chronic obstructive pulmonary disease (COPD) with depression
1 finding from 1 review
Change in exercise tolerance · chronic obstructive pulmonary disease (COPD) with depression
1 finding from 1 review
Change in hospital utilisation ‐ not measured · chronic obstructive pulmonary disease (COPD) with depression
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Pneumonia, community acquired, at least 1 episode · patients with COPD
The intervention probably leads to lower pneumonia, community acquired, at least 1 episode (moderate certainty).
1 finding from 1 review
Intervention not reported
Pneumococcal pneumonia, at least 1 episode · patients with COPD
The intervention showed no clear difference in pneumococcal pneumonia, at least 1 episode (low certainty).
1 finding from 1 review
Intervention not reported
Death from cardiorespiratory causes · patients with COPD
The intervention showed no clear difference in death from cardiorespiratory causes (moderate certainty).
1 finding from 1 review
Intervention not reported
Death from all causes · patients with COPD
The intervention showed no clear difference in death from all causes (moderate certainty).
1 finding from 1 review
Intervention not reported
Hospital admission: any cause, at least 1 episode · patients with COPD
The intervention showed no clear difference in hospital admission: any cause, at least 1 episode (moderate certainty).
1 finding from 1 review
Intervention not reported
COPD exacerbation: at least 1 episode · patients with COPD
The intervention probably leads to lower COPD exacerbation: at least 1 episode (moderate certainty).
1 finding from 1 review
Intervention not reported
Lung function: FEV1 (L) · patients with COPD
1 finding from 1 review
Death or bronchopulmonary dysplasia at 36 weeks PMA · Neonates with developing BPD
Inhaled steroids showed no clear difference in death or BPD at 36 weeks' postmenstrual age compared with systemic steroids (moderate certainty).
2 findings from 1 review
Diastolic blood pressure > 95th percentile at 7 years · Neonates with developing BPD
Inhaled steroids probably leads to lower diastolic blood pressure > 95th percentile at 7 years compared with systemic steroids (moderate certainty).
1 finding from 1 review
Ever diagnosed as asthmatic by 7 years · Neonates with developing BPD
Inhaled steroids showed no clear difference in ever diagnosed as asthmatic by 7 years compared with systemic steroids (moderate certainty).
1 finding from 1 review
Bronchopulmonary dysplasia/chronic lung disease · Neonates with developing BPD
Inhaled steroids showed no clear difference in BPD at 36 weeks' postmenstrual age compared with systemic steroids (low certainty).
1 finding from 1 review
Hyperglycaemia · Neonates with developing BPD
Inhaled steroids showed no clear difference in hyperglycaemia compared with systemic steroids (low certainty).
1 finding from 1 review
Hypertension · Neonates with developing BPD
Inhaled steroids may leads to lower hypertension compared with systemic steroids (low certainty).
1 finding from 1 review
General conceptual ability (GCA) score at 7 years The test has a standardisation mean of 100 and SD of 15 · Neonates with developing BPD
Inhaled steroids showed no clear difference in general conceptual ability (GCA) score at 7 years The test has a… compared with systemic steroids (moderate certainty).
1 finding from 1 review
Moderate/severe disability at 7 years · Neonates with developing BPD
Inhaled steroids showed no clear difference in moderate/severe disability at 7 years compared with systemic steroids (moderate certainty).
1 finding from 1 review
Death or moderate/severe disability at 7 years · Neonates with developing BPD
Inhaled steroids showed no clear difference in death or moderate/severe disability at 7 years compared with systemic steroids (moderate certainty).
1 finding from 1 review
Systolic blood pressure > 95th percentile at 7 years · Neonates with developing BPD
Inhaled steroids showed no clear difference in systolic blood pressure > 95th percentile at 7 years compared with systemic steroids (moderate certainty).
1 finding from 1 review